Wells Fargo’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Buy |
217,134
+47,782
| +28% | +$1M | ﹤0.01% | 2306 |
|
|
2025
Q1 | $2.77M | Buy |
169,352
+18,833
| +13% | +$308K | ﹤0.01% | 2569 |
|
|
2024
Q4 | $3.87M | Sell |
150,519
-3,093
| -2% | -$79.5K | ﹤0.01% | 2315 |
|
|
2024
Q3 | $4.87M | Buy |
153,612
+4,388
| +3% | +$139K | ﹤0.01% | 2132 |
|
|
2024
Q2 | $5.24M | Buy |
149,224
+23,972
| +19% | +$842K | ﹤0.01% | 2023 |
|
|
2024
Q1 | $5.5M | Buy |
125,252
+108,031
| +627% | +$4.74M | ﹤0.01% | 1977 |
|
|
2023
Q4 | $613K | Sell |
17,221
-18,670
| -52% | -$664K | ﹤0.01% | 3387 |
|
|
2023
Q3 | $968K | Sell |
35,891
-7,272
| -17% | -$196K | ﹤0.01% | 3106 |
|
|
2023
Q2 | $1.01M | Buy |
43,163
+13,555
| +46% | +$319K | ﹤0.01% | 3282 |
|
|
2023
Q1 | $407K | Buy |
29,608
+29,091
| +5,627% | +$399K | ﹤0.01% | 3743 |
|
|
2022
Q4 | $9.39K | Sell |
517
-1,080
| -68% | -$19.6K | ﹤0.01% | 5251 |
|
|
2022
Q3 | $24K | Buy |
1,597
+197
| +14% | +$2.96K | ﹤0.01% | 4983 |
|
|
2022
Q2 | $19K | Sell |
1,400
-31,272
| -96% | -$424K | ﹤0.01% | 5191 |
|
|
2022
Q1 | $365K | Sell |
32,672
-9,034
| -22% | -$101K | ﹤0.01% | 4350 |
|
|
2021
Q4 | $986K | Buy |
41,706
+18,424
| +79% | +$436K | ﹤0.01% | 3859 |
|
|
2021
Q3 | $593K | Sell |
23,282
-1,933
| -8% | -$49.2K | ﹤0.01% | 4314 |
|
|
2021
Q2 | $529K | Buy |
25,215
+5,155
| +26% | +$108K | ﹤0.01% | 4323 |
|
|
2021
Q1 | $472K | Sell |
20,060
-16,903
| -46% | -$398K | ﹤0.01% | 4418 |
|
|
2020
Q4 | $517K | Buy |
36,963
+23,909
| +183% | +$334K | ﹤0.01% | 4409 |
|
|
2020
Q3 | $164K | Buy |
13,054
+6,338
| +94% | +$79.6K | ﹤0.01% | 4877 |
|
|
2020
Q2 | $95K | Buy |
6,716
+6,681
| +19,089% | +$94.5K | ﹤0.01% | 5031 |
|
|
2020
Q1 | $0 | Buy |
+35
| New | – | ﹤0.01% | 6067 |
|